This article from Biotech Metro highlights how Reselute is developing innovative medical device technology designed to address complex orthopedic infections.

Reselute is proud to announce that the company has been awarded a National Institutes of Health (NIH) FastTrack SBIR combined

The Reselution™ Tibial Intramedullary Fixation System has received FDA Breakthrough Device Designation, recognizing its potential to provide more effective treatment

This article from Duke University’s Office of Technology Commercialization highlights how Cambre Kelly’s collaboration with a Duke faculty member led

This featured video from Ortho Innovators highlights Cambre Kelly’s perspective on biomedical engineering and innovation within orthopedics. The conversation explores emerging technologies,

In Catching Up with Cambre Kelly, Ph.D., BoneZone reconnects with Dr. Kelly to discuss her career progression, research interests, and